Header image

Clinical and molecular neuro-oncology research (Neuro-Oncology Parallel Session)

Tracks
Hall 1
Tuesday, October 7, 2025
8:00 AM - 9:30 AM

Speakers & Chairs

Emilie Le Rhun

Chair

Nikolaos Foroglou

Chair

Malte Mohme

Neuro-Immune Crosstalk – Evolutionary immunosuppression in trauma and cancer

8:00 AM - 8:10 AM
Joonas Haapasalo

CSF liquid biopsy diagnostics in brain tumors

8:10 AM - 8:20 AM
Emilie Le Rhun

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant

8:20 AM - 8:30 AM
Prof Tao Xu
Vice Chairman
Shanghai Changzheng Hospital, Naval Medical University

Defect-Engineered 2D Black Ferroelectric Perovskite Nanocatalysts for Augmented Piezocatalytic Glioma Therapy

8:30 AM - 8:37 AM
Dr Manina Etter
Resident
University Hospital

Combating Glioblastoma: Enhancing anti-EGFRvIII CAR T Cell Therapy with a Paracrine SIRP -derived CD47 Blocker – A Proof-of-Concept Preclinical Study Translating into a First-in-Human Phase I Clinical Trialac

8:37 AM - 8:44 AM
Dr Jonas Ort
Resident
Rwth Aachen University

Glioblastoma cell infiltration induces neuronal hyperexcitability and alters peritumoral network connectivity properties in an in-vitro model of human brain slice cultures.

8:44 AM - 8:51 AM
Dr Anna Zeitlberger
Attending
HOCH Health Ostschweiz, University teaching and research hospital

The Intra-humoral Heterogeneity of the Antigenic Landscape in Glioblastoma

8:51 AM - 8:58 AM
Dr Harald Krenzlin
Attending
Uksh Lübeck

Interim analysis of the International IM4 Study: Clinical course of primary IDH-mutant astrocytoma CNS-WHO grade 4 and formerly known primary IDH-mutant glioblastoma WHO grade IV

8:58 AM - 9:05 AM
Dr Eduardo Erasmo Mendoza Mireles
Specialist
Oslo University Hospital

A International Multicenter Cohort Study of Surgery for Recurrent Brain Metastases (RECMET) – An EANS Section of Neuro-Oncology Initiative

9:05 AM - 9:12 AM
Mr Carlos Aude
Medical Student
Johns Hopkins University School of Medicine

Glucagon-Like Peptide-1 Receptor Agonists and Primary Malignant Brain Tumor Risk in Type 2 Diabetes

9:12 AM - 9:19 AM
loading